Products

LandiNuxt

Skill

The AI-Agent-Ready Nuxt Landing Library

landinuxt.com Software Development / Boilerplates, Templates & UI Components

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Free
No monthly subscription pricing
Creators
César
@cesswhite_· 373 followers
Launched
2y ago
2024-11-12 · Est.

Traffic

Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Effortless landing page creation

    Nov 13, 2024 · 2y agoLaunch page

  • Launched on Uneed (#3)Launch

    LandiNuxt — Build beautiful, responsive landing pages effortlessly with LandiNuxt.

    Nov 12, 2024 · 2y agoLaunch page

Open Source & Agent Ecosystem

GitHub · MCP / Skill
GitHub Stars
Public repo
Forks
—
License
See repository
Primary language
—

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2024-10-26

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Website does not list public plan prices.

Trial: None · Observed 2026-11-07 · Source page

Pages & changes

Tracked since 2024-11-13

Key pages

Weekly snapshots
www.landinuxt.com/ Snapshot 2026-11-08

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does LandiNuxt get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is LandiNuxt and what platforms does it support?
LandiNuxt is catalogued under Boilerplates, Templates & UI Components: The AI-Agent-Ready Nuxt Landing Library. Supported platforms: CLI / SDK.

Related products in this category

Software Development / Boilerplates, Templates & UI Components

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.